Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jason Gerberry's Stock Ratings
B of A Securities Analyst
Jason Gerberry is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/17/2025
Overall Average Return
5.86%
Smart Score
Overall Average Return Percentile
50th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/11/2025 | LQDA | Buy Now | Liquidia | $14.02 | 64.05% | Jason Gerberry63% | $25 → $23 | Maintains | Buy | Get Alert |
| 06/05/2025 | EXEL | Buy Now | Exelixis | $41.12 | 11.88% | Jason Gerberry63% | $45 → $46 | Maintains | Neutral | Get Alert |
| 05/08/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | 26.15% | Jason Gerberry63% | $20 → $22 | Maintains | Buy | Get Alert |
| 04/01/2025 | PCVX | Buy Now | Vaxcyte | $34.05 | 302.35% | Jason Gerberry63% | $157 → $137 | Maintains | Buy | Get Alert |
| 03/20/2025 | IMVT | Buy Now | Immunovant | $15.50 | 112.9% | Jason Gerberry63% | $38 → $33 | Maintains | Buy | Get Alert |
| 03/06/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | 14.68% | Jason Gerberry63% | $23 → $20 | Maintains | Buy | Get Alert |
| 02/28/2025 | VTRS | Buy Now | Viatris | $8.93 | 11.98% | Jason Gerberry63% | $11 → $10 | Maintains | Underperform | Get Alert |
| 02/11/2025 | AXSM | Buy Now | Axsome Therapeutics | $101.00 | 65.35% | Jason Gerberry63% | $143 → $167 | Maintains | Buy | Get Alert |
| 01/15/2025 | IMVT | Buy Now | Immunovant | $15.50 | 190.32% | Jason Gerberry63% | $48 → $45 | Maintains | Buy | Get Alert |
| 01/09/2025 | CPRX | Buy Now | Catalyst Pharmaceuticals | $23.66 | 26.8% | Jason Gerberry63% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 12/17/2024 | EXEL | Buy Now | Exelixis | $41.12 | -5.15% | Jason Gerberry63% | $35 → $39 | Downgrade | Buy → Neutral | Get Alert |
| 11/15/2024 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $3 → $0.5 | Downgrade | Buy → Neutral | Get Alert |
| 11/06/2024 | ACLX | Buy Now | Arcellx | $64.30 | 55.52% | Jason Gerberry63% | $84 → $100 | Maintains | Buy | Get Alert |
| 10/15/2024 | EXEL | Buy Now | Exelixis | $41.12 | -22.17% | Jason Gerberry63% | $30 → $32 | Maintains | Buy | Get Alert |
| 09/24/2024 | BHVN | Buy Now | Biohaven | $15.50 | 300% | Jason Gerberry63% | $52 → $62 | Maintains | Buy | Get Alert |
| 09/10/2024 | RLAY | Buy Now | Relay Therapeutics | $3.27 | 633.94% | Jason Gerberry63% | $20 → $24 | Maintains | Buy | Get Alert |
| 09/04/2024 | PROK | Buy Now | ProKidney | $0.96 | 213.05% | Jason Gerberry63% | $4 → $3 | Maintains | Neutral | Get Alert |
| 09/04/2024 | PCVX | Buy Now | Vaxcyte | $34.05 | 311.16% | Jason Gerberry63% | $101 → $140 | Maintains | Buy | Get Alert |
| 08/20/2024 | LQDA | Buy Now | Liquidia | $14.02 | 64.05% | Jason Gerberry63% | $24 → $23 | Maintains | Buy | Get Alert |
| 08/15/2024 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $4 → $3 | Maintains | Buy | Get Alert |
| 08/06/2024 | AXSM | Buy Now | Axsome Therapeutics | $101.00 | 4.95% | Jason Gerberry63% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 07/23/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $35.24 | 92.96% | Jason Gerberry63% | $67 → $68 | Maintains | Buy | Get Alert |
| 07/18/2024 | AXSM | Buy Now | Axsome Therapeutics | $101.00 | -5.94% | Jason Gerberry63% | $97 → $95 | Maintains | Neutral | Get Alert |
| 07/16/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $35.24 | 90.12% | Jason Gerberry63% | $64 → $67 | Maintains | Buy | Get Alert |
| 06/21/2024 | PCVX | Buy Now | Vaxcyte | $34.05 | 196.62% | Jason Gerberry63% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
| 06/11/2024 | OCS | Buy Now | Oculis Holding | $19.56 | 2.25% | Jason Gerberry63% | $21 → $20 | Maintains | Buy | Get Alert |
| 05/30/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | 20.41% | Jason Gerberry63% | $18 → $21 | Maintains | Buy | Get Alert |
| 05/29/2024 | PROK | Buy Now | ProKidney | $0.96 | 317.41% | Jason Gerberry63% | $3 → $4 | Maintains | Neutral | Get Alert |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | Jason Gerberry63% | $82 → $91 | Maintains | Buy | Get Alert |
| 04/01/2024 | GLPG | Buy Now | Galapagos | $28.29 | 9.58% | Jason Gerberry63% | $41 → $31 | Downgrade | Neutral → Underperform | Get Alert |
| 03/28/2024 | GLPG | Buy Now | Galapagos | $28.29 | 9.58% | Jason Gerberry63% | $41 → $31 | Downgrade | Neutral → Underperform | Get Alert |
| 03/25/2024 | LYRA | Buy Now | Lyra Therapeutics | $11.50 | -4.35% | Jason Gerberry63% | $12 → $11 | Maintains | Buy | Get Alert |
| 03/07/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $23.66 | -2.79% | Jason Gerberry63% | → $23 | Initiates | → Buy | Get Alert |
| 02/06/2024 | PCVX | Buy Now | Vaxcyte | $34.05 | 170.19% | Jason Gerberry63% | $80 → $92 | Maintains | Buy | Get Alert |
| 01/02/2024 | ALKS | Buy Now | Alkermes | $30.12 | -3.72% | Jason Gerberry63% | $27 → $29 | Maintains | Neutral | Get Alert |
| 01/02/2024 | ARWR | Buy Now | Arrowhead Pharma | $15.18 | 143.74% | Jason Gerberry63% | $29 → $37 | Maintains | Buy | Get Alert |
| 01/02/2024 | GLPG | Buy Now | Galapagos | $28.29 | 55.53% | Jason Gerberry63% | $41 → $44 | Maintains | Neutral | Get Alert |
| 01/02/2024 | PCVX | Buy Now | Vaxcyte | $34.05 | 134.95% | Jason Gerberry63% | $67 → $80 | Maintains | Buy | Get Alert |
| 01/02/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $32.02 | 74.89% | Jason Gerberry63% | $52 → $56 | Maintains | Buy | Get Alert |
| 01/02/2024 | PROK | Buy Now | ProKidney | $0.96 | 108.7% | Jason Gerberry63% | $8 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 01/02/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $35.24 | 75.94% | Jason Gerberry63% | $52 → $62 | Upgrade | Neutral → Buy | Get Alert |
| 01/02/2024 | HRMY | Buy Now | Harmony Biosciences | $32.95 | -8.95% | Jason Gerberry63% | → $30 | Downgrade | Neutral → Underperform | Get Alert |
| 12/21/2023 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $12 → $5 | Maintains | Buy | Get Alert |
| 12/21/2023 | IMVT | Buy Now | Immunovant | $15.50 | 229.03% | Jason Gerberry63% | $49 → $51 | Maintains | Buy | Get Alert |
| 12/11/2023 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $11 → $12 | Maintains | Buy | Get Alert |
| 12/04/2023 | ARWR | Buy Now | Arrowhead Pharma | $15.18 | 91.04% | Jason Gerberry63% | → $29 | Initiates | → Buy | Get Alert |
| 11/17/2023 | AMPH | Buy Now | Amphastar Pharma | $25.97 | 142.59% | Jason Gerberry63% | → $63 | Initiates | → Neutral | Get Alert |
| 10/26/2023 | PCVX | Buy Now | Vaxcyte | $34.05 | 516.74% | Jason Gerberry63% | → $210 | Initiates | → Neutral | Get Alert |
| 10/23/2023 | VTRS | Buy Now | Viatris | $8.93 | 0.78% | Jason Gerberry63% | → $9 | Downgrade | Neutral → Underperform | Get Alert |
| 10/23/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $35.24 | 47.56% | Jason Gerberry63% | $33 → $52 | Upgrade | Underperform → Neutral | Get Alert |
| 09/12/2023 | LYRA | Buy Now | Lyra Therapeutics | $11.50 | 30.43% | Jason Gerberry63% | $13 → $15 | Maintains | Buy | Get Alert |
| 09/08/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -25.46% | Jason Gerberry63% | $12 → $13 | Maintains | Buy | Get Alert |
| 09/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jason Gerberry63% | $304 → $259 | Maintains | Buy | Get Alert |
| 08/30/2023 | OCS | Buy Now | Oculis Holding | $19.56 | 22.7% | Jason Gerberry63% | $23 → $24 | Maintains | Buy | Get Alert |
| 08/10/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $109.51 | 98.16% | Jason Gerberry63% | $204 → $217 | Maintains | Buy | Get Alert |
| 08/09/2023 | PCVX | Buy Now | Vaxcyte | $34.05 | 96.77% | Jason Gerberry63% | $66 → $67 | Maintains | Buy | Get Alert |
| 08/08/2023 | FGEN | Buy Now | FibroGen | $6.05 | -66.94% | Jason Gerberry63% | $4 → $2 | Downgrade | Neutral → Underperform | Get Alert |
| 08/08/2023 | AXSM | Buy Now | Axsome Therapeutics | $101.00 | -19.8% | Jason Gerberry63% | $59 → $81 | Upgrade | Underperform → Neutral | Get Alert |
| 07/19/2023 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $6 → $10 | Upgrade | Neutral → Buy | Get Alert |
| 06/26/2023 | FGEN | Buy Now | FibroGen | $6.05 | -33.88% | Jason Gerberry63% | $29 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 06/14/2023 | OCS | Buy Now | Oculis Holding | $19.56 | 12.47% | Jason Gerberry63% | → $22 | Initiates | → Buy | Get Alert |
| 05/24/2023 | LLY | Buy Now | Eli Lilly | $804.99 | -37.89% | Jason Gerberry63% | $450 → $500 | Maintains | Buy | Get Alert |
| 05/23/2023 | IMVT | Buy Now | Immunovant | $15.50 | 80.65% | Jason Gerberry63% | $26 → $28 | Maintains | Buy | Get Alert |
| 05/16/2023 | CARA | Buy Now | Cara Therapeutics | — | — | Jason Gerberry63% | $6 → $4 | Maintains | Underperform | Get Alert |
| 05/11/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -36.93% | Jason Gerberry63% | $13 → $11 | Maintains | Buy | Get Alert |
| 05/10/2023 | ACLX | Buy Now | Arcellx | $64.30 | -22.24% | Jason Gerberry63% | $39 → $50 | Maintains | Buy | Get Alert |
| 05/01/2023 | IMVT | Buy Now | Immunovant | $15.50 | 67.74% | Jason Gerberry63% | → $26 | Initiates | → Buy | Get Alert |
| 04/20/2023 | HRMY | Buy Now | Harmony Biosciences | $32.95 | 6.22% | Jason Gerberry63% | → $35 | Initiates | → Neutral | Get Alert |
| 04/18/2023 | PCVX | Buy Now | Vaxcyte | $34.05 | 99.71% | Jason Gerberry63% | $63 → $68 | Maintains | Buy | Get Alert |
| 03/30/2023 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $8 → $6 | Maintains | Neutral | Get Alert |
| 03/08/2023 | CARA | Buy Now | Cara Therapeutics | — | — | Jason Gerberry63% | $13 → $6 | Downgrade | Neutral → Underperform | Get Alert |
| 02/28/2023 | PCVX | Buy Now | Vaxcyte | $34.05 | 85.02% | Jason Gerberry63% | $64 → $63 | Maintains | Buy | Get Alert |
| 02/14/2023 | AXSM | Buy Now | Axsome Therapeutics | $101.00 | -48.51% | Jason Gerberry63% | → $52 | Reiterates | → Underperform | Get Alert |
| 01/05/2023 | AMTI | Buy Now | Applied Molecular | — | — | Jason Gerberry63% | $5 → $0.5 | Downgrade | Buy → Underperform | Get Alert |
| 01/05/2023 | FGEN | Buy Now | FibroGen | $6.05 | 346.28% | Jason Gerberry63% | $18 → $27 | Upgrade | Neutral → Buy | Get Alert |
| 12/13/2022 | ACLX | Buy Now | Arcellx | $64.30 | -42.46% | Jason Gerberry63% | → $37 | Reinstates | → Buy | Get Alert |
| 12/12/2022 | ALLO | Buy Now | Allogene Therapeutics | $1.37 | 556.93% | Jason Gerberry63% | → $9 | Downgrade | Buy → Underperform | Get Alert |
| 10/14/2022 | ALKS | Buy Now | Alkermes | $30.12 | -17% | Jason Gerberry63% | $27 → $25 | Upgrade | Underperform → Neutral | Get Alert |
| 10/14/2022 | OGN | Buy Now | Organon | $10.15 | 146.31% | Jason Gerberry63% | $37 → $25 | Downgrade | Neutral → Underperform | Get Alert |
| 08/29/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $32.02 | — | Jason Gerberry63% | — | Initiates | → Buy | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Jason Gerberry63% | $160 → $261 | Maintains | Buy | Get Alert |
| 08/05/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -25.46% | Jason Gerberry63% | $10 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 08/05/2022 | OGN | Buy Now | Organon | $10.15 | 264.53% | Jason Gerberry63% | $40 → $37 | Downgrade | Buy → Neutral | Get Alert |
| 05/17/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -48.39% | Jason Gerberry63% | → $9 | Upgrade | Underperform → Neutral | Get Alert |
| 03/01/2022 | VTRS | Buy Now | Viatris | $8.93 | 45.58% | Jason Gerberry63% | $21 → $13 | Downgrade | Buy → Neutral | Get Alert |
| 03/01/2022 | ACLX | Buy Now | Arcellx | $64.30 | -62.67% | Jason Gerberry63% | → $24 | Initiates | → Buy | Get Alert |
| 02/01/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jason Gerberry63% | $171 → $141 | Upgrade | Underperform → Neutral | Get Alert |
| 02/01/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $35.24 | -14.87% | Jason Gerberry63% | $40 → $30 | Downgrade | Buy → Underperform | Get Alert |
| 12/02/2021 | BYSI | Buy Now | BeyondSpring | $2.67 | 87.27% | Jason Gerberry63% | $45 → $5 | Downgrade | Buy → Underperform | Get Alert |
| 10/11/2021 | DICE | Buy Now | DICE Therapeutics | — | — | Jason Gerberry63% | → $41 | Initiates | → Buy | Get Alert |
| 09/02/2021 | ALKS | Buy Now | Alkermes | $30.12 | -10.36% | Jason Gerberry63% | → $27 | Downgrade | Neutral → Underperform | Get Alert |
| 09/01/2021 | OGN | Buy Now | Organon | $10.15 | 323.65% | Jason Gerberry63% | → $43 | Initiates | → Buy | Get Alert |
| 07/16/2021 | FGEN | Buy Now | FibroGen | $6.05 | 379.34% | Jason Gerberry63% | → $29 | Downgrade | Buy → Neutral | Get Alert |
| 04/13/2021 | FNCH | Buy Now | Finch Therapeutics Gr | $13.60 | 83.82% | Jason Gerberry63% | → $25 | Initiates | → Buy | Get Alert |
| 03/31/2021 | FGEN | Buy Now | FibroGen | $6.05 | 676.86% | Jason Gerberry63% | → $47 | Upgrade | Neutral → Buy | Get Alert |
| 03/24/2021 | BHC | Buy Now | Bausch Health Companies | $5.98 | 351.51% | Jason Gerberry63% | → $27 | Downgrade | Neutral → Underperform | Get Alert |
| 01/22/2021 | LLY | Buy Now | Eli Lilly | $804.99 | -72.05% | Jason Gerberry63% | $195 → $225 | Maintains | Buy | Get Alert |
| 01/11/2021 | BYSI | Buy Now | BeyondSpring | $2.67 | 836.33% | Jason Gerberry63% | → $25 | Initiates | → Buy | Get Alert |
| 11/17/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jason Gerberry63% | → $196 | Downgrade | Neutral → Underperform | Get Alert |
| 11/05/2020 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $100 → $81 | Maintains | Buy | Get Alert |
| 10/19/2020 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | Jason Gerberry63% | → $9 | Downgrade | Neutral → Underperform | Get Alert |
| 09/30/2020 | ALKS | Buy Now | Alkermes | $30.12 | -36.92% | Jason Gerberry63% | $21 → $19 | Maintains | Neutral | Get Alert |
| 09/30/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Jason Gerberry63% | $75 → $85 | Maintains | Buy | Get Alert |
| 09/28/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Jason Gerberry63% | → $172 | Initiates | → Neutral | Get Alert |
| 09/17/2020 | BHC | Buy Now | Bausch Health Companies | $5.98 | 217.73% | Jason Gerberry63% | $16 → $19 | Upgrade | Underperform → Neutral | Get Alert |
| 08/21/2020 | GLPG | Buy Now | Galapagos | $28.29 | 373.67% | Jason Gerberry63% | $148 → $134 | Maintains | Underperform | Get Alert |
| 08/17/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | Jason Gerberry63% | $92 → $95 | Maintains | Buy | Get Alert |
| 07/16/2020 | CHRS | Buy Now | Coherus BioSciences | $0.79 | 2431.65% | Jason Gerberry63% | → $20 | Initiates | → Neutral | Get Alert |
| 07/15/2020 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.63 | 1486.29% | Jason Gerberry63% | $17 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 07/13/2020 | BLUE | Buy Now | bluebird bio | — | — | Jason Gerberry63% | $104 → $100 | Maintains | Buy | Get Alert |
| 07/13/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Jason Gerberry63% | → $92 | Initiates | → Buy | Get Alert |
| 07/07/2020 | BHC | Buy Now | Bausch Health Companies | $5.98 | 134.11% | Jason Gerberry63% | $12 → $14 | Maintains | Underperform | Get Alert |
| 06/30/2020 | AMTI | Buy Now | Applied Molecular | — | — | Jason Gerberry63% | → $34 | Initiates | → Buy | Get Alert |
| 06/19/2020 | LLY | Buy Now | Eli Lilly | $804.99 | -77.64% | Jason Gerberry63% | $165 → $180 | Maintains | Buy | Get Alert |
| 06/18/2020 | JAZZ | Buy Now | Jazz Pharmaceuticals | $109.51 | 52.5% | Jason Gerberry63% | $165 → $167 | Maintains | Buy | Get Alert |
| 05/26/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | Jason Gerberry63% | $52 → $57 | Reiterates | → Buy | Get Alert |
| 05/26/2020 | LYRA | Buy Now | Lyra Therapeutics | $11.50 | 82.61% | Jason Gerberry63% | → $21 | Initiates | → Buy | Get Alert |
| 05/18/2020 | ABBV | Buy Now | AbbVie | $190.16 | -50.04% | Jason Gerberry63% | → $95 | Reinstates | → Neutral | Get Alert |
| 05/08/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -54.13% | Jason Gerberry63% | $7 → $8 | Reiterates | → Underperform | Get Alert |
| 04/27/2020 | FGEN | Buy Now | FibroGen | $6.05 | 643.8% | Jason Gerberry63% | → $45 | Initiates | → Neutral | Get Alert |
| 03/26/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Jason Gerberry63% | $47 → $56 | Upgrade | Neutral → Buy | Get Alert |
| 03/23/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -59.86% | Jason Gerberry63% | $11 → $7 | Maintains | Underperform | Get Alert |
| 03/23/2020 | JAZZ | Buy Now | Jazz Pharmaceuticals | $109.51 | 48.84% | Jason Gerberry63% | $178 → $163 | Maintains | Buy | Get Alert |
| 03/23/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | Jason Gerberry63% | $45 → $42 | Maintains | Buy | Get Alert |
| 03/23/2020 | ALKS | Buy Now | Alkermes | $30.12 | -43.56% | Jason Gerberry63% | $20 → $17 | Maintains | Neutral | Get Alert |
| 03/23/2020 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | Jason Gerberry63% | $26 → $17 | Maintains | Neutral | Get Alert |
| 02/24/2020 | GLPG | Buy Now | Galapagos | $28.29 | 652.92% | Jason Gerberry63% | → $213 | Downgrade | Neutral → Underperform | Get Alert |
| 02/13/2020 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -36.93% | Jason Gerberry63% | $8 → $11 | Maintains | Underperform | Get Alert |
| 12/02/2019 | GLPG | Buy Now | Galapagos | $28.29 | 603.43% | Jason Gerberry63% | → $199 | Initiates | → Neutral | Get Alert |
| 11/13/2019 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Jason Gerberry63% | → $51 | Initiates | → Neutral | Get Alert |
| 10/17/2019 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 23.76% | Jason Gerberry63% | → $60 | Reinstates | → Buy | Get Alert |
| 10/17/2019 | LLY | Buy Now | Eli Lilly | $804.99 | -83.48% | Jason Gerberry63% | → $133 | Reinstates | → Buy | Get Alert |
| 10/17/2019 | PFE | Buy Now | Pfizer | $24.34 | 52.01% | Jason Gerberry63% | → $37 | Reinstates | → Neutral | Get Alert |
| 10/17/2019 | MRK | Buy Now | Merck & Co | $80.60 | 11.66% | Jason Gerberry63% | → $90 | Reinstates | → Neutral | Get Alert |
| 10/10/2019 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 3.14% | Jason Gerberry63% | $49 → $50 | Reiterates | → Neutral | Get Alert |
| 09/26/2019 | HZNP | Buy Now | Horizon Therapeutics | — | — | Jason Gerberry63% | → $34 | Initiates | → Buy | Get Alert |
| 09/10/2019 | LLY | Buy Now | Eli Lilly | $804.99 | -85.09% | Jason Gerberry63% | $118 → $120 | Reiterates | → Neutral | Get Alert |
| 09/03/2019 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 1.07% | Jason Gerberry63% | $46 → $49 | Maintains | Neutral | Get Alert |
| 07/30/2019 | PFE | Buy Now | Pfizer | $24.34 | — | Jason Gerberry63% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/30/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -48.39% | Jason Gerberry63% | $19 → $9 | Downgrade | Buy → Underperform | Get Alert |
| 05/01/2019 | MRK | Buy Now | Merck & Co | $80.60 | 12.9% | Jason Gerberry63% | $90 → $91 | Maintains | Buy | Get Alert |
| 04/01/2019 | PFE | Buy Now | Pfizer | $24.34 | 97.21% | Jason Gerberry63% | $45 → $48 | Maintains | Buy | Get Alert |
| 03/20/2019 | BHC | Buy Now | Bausch Health Companies | $5.98 | 201% | Jason Gerberry63% | → $18 | Reinstates | → Underperform | Get Alert |
| 02/19/2019 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 5.2% | Jason Gerberry63% | $53 → $51 | Maintains | Neutral | Get Alert |
| 01/03/2019 | ABBV | Buy Now | AbbVie | $190.16 | — | Jason Gerberry63% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2019 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | — | Jason Gerberry63% | — | Upgrade | Underperform → Buy | Get Alert |
| 12/12/2018 | FOMX | Buy Now | Foamix Pharmaceuticals | — | — | Jason Gerberry63% | → $11 | Initiates | → Buy | Get Alert |
| 11/06/2018 | MYL | Buy Now | Mylan | — | — | Jason Gerberry63% | $44 → $42 | Upgrade | Neutral → Buy | Get Alert |
| 11/02/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | 14.68% | Jason Gerberry63% | $19 → $20 | Maintains | Underperform | Get Alert |
| 10/04/2018 | ABBV | Buy Now | AbbVie | $190.16 | -44.26% | Jason Gerberry63% | $107 → $106 | Maintains | Buy | Get Alert |
| 08/27/2018 | NBRV | Buy Now | Nabriva Therapeutics | — | — | Jason Gerberry63% | $9 → $5 | Maintains | Buy | Get Alert |
| 08/22/2018 | ABBV | Buy Now | AbbVie | $190.16 | -43.73% | Jason Gerberry63% | $105 → $107 | Maintains | Buy | Get Alert |
| 08/01/2018 | PFE | Buy Now | Pfizer | $24.34 | 76.66% | Jason Gerberry63% | $42 → $43 | Maintains | Buy | Get Alert |
| 07/30/2018 | ABBV | Buy Now | AbbVie | $190.16 | -44.78% | Jason Gerberry63% | $112 → $105 | Maintains | Buy | Get Alert |
| 07/30/2018 | MRK | Buy Now | Merck & Co | $80.60 | -8.19% | Jason Gerberry63% | $70 → $74 | Maintains | Buy | Get Alert |
| 07/27/2018 | ALKS | Buy Now | Alkermes | $30.12 | 79.28% | Jason Gerberry63% | $56 → $54 | Maintains | Buy | Get Alert |
| 07/25/2018 | LLY | Buy Now | Eli Lilly | $804.99 | -88.32% | Jason Gerberry63% | $90 → $94 | Maintains | Neutral | Get Alert |
| 07/17/2018 | LLY | Buy Now | Eli Lilly | $804.99 | -88.82% | Jason Gerberry63% | $86 → $90 | Maintains | Neutral | Get Alert |
| 06/12/2018 | AGN | Buy Now | Allergan | — | — | Jason Gerberry63% | $209 → $213 | Maintains | Buy | Get Alert |
| 05/29/2018 | MYL | Buy Now | Mylan | — | — | Jason Gerberry63% | $43 → $42 | Maintains | Neutral | Get Alert |
| 05/22/2018 | NBRV | Buy Now | Nabriva Therapeutics | — | — | Jason Gerberry63% | $10 → $11 | Maintains | Buy | Get Alert |
| 05/11/2018 | ALKS | Buy Now | Alkermes | $30.12 | 85.92% | Jason Gerberry63% | → $56 | Initiates | → Buy | Get Alert |
| 05/01/2018 | AGN | Buy Now | Allergan | — | — | Jason Gerberry63% | $213 → $209 | Maintains | Buy | Get Alert |
| 04/18/2018 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 25.83% | Jason Gerberry63% | $68 → $61 | Maintains | Neutral | Get Alert |
| 04/18/2018 | MRK | Buy Now | Merck & Co | $80.60 | -13.15% | Jason Gerberry63% | $68 → $70 | Maintains | Buy | Get Alert |
| 04/17/2018 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 25.83% | Jason Gerberry63% | $68 → $61 | Maintains | Neutral | Get Alert |
| 04/17/2018 | MRK | Buy Now | Merck & Co | $80.60 | -13.15% | Jason Gerberry63% | $68 → $70 | Maintains | Buy | Get Alert |
| 03/05/2018 | BMY | Buy Now | Bristol-Myers Squibb | $48.48 | 40.26% | Jason Gerberry63% | $64 → $68 | Maintains | Neutral | Get Alert |
| 02/20/2018 | JAZZ | Buy Now | Jazz Pharmaceuticals | $109.51 | 55.24% | Jason Gerberry63% | $164 → $170 | Maintains | Buy | Get Alert |
| 02/09/2018 | TEVA | Buy Now | Teva Pharmaceutical Indus | $17.44 | -8.26% | Jason Gerberry63% | $17 → $16 | Maintains | Underperform | Get Alert |
| 02/07/2018 | AGN | Buy Now | Allergan | — | — | Jason Gerberry63% | $208 → $215 | Maintains | Buy | Get Alert |
| 02/01/2018 | LLY | Buy Now | Eli Lilly | $804.99 | -89.32% | Jason Gerberry63% | $88 → $86 | Maintains | Neutral | Get Alert |
| 11/28/2017 | MRK | Buy Now | Merck & Co | $80.60 | -20.6% | Jason Gerberry63% | → $64 | Reinstates | Buy → Buy | Get Alert |
| 02/22/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Jason Gerberry63% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/15/2017 | BIVV | Buy Now | Bioverativ | — | — | Jason Gerberry63% | → $56 | Initiates | → Outperform | Get Alert |
| 12/22/2016 | CRME | Buy Now | Cardiome Pharma Corporation - Ordinary Shares (Canada) | — | — | Jason Gerberry63% | — | Initiates | → Outperform | Get Alert |
| 10/13/2016 | MRK | Buy Now | Merck & Co | $80.60 | — | Jason Gerberry63% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/04/2016 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Jason Gerberry63% | $21 → $18 | Maintains | Outperform | Get Alert |
| 01/27/2016 | MRK | Buy Now | Merck & Co | $80.60 | — | Jason Gerberry63% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/05/2015 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Jason Gerberry63% | $25 → $22 | Maintains | Outperform | Get Alert |
| 10/13/2015 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Jason Gerberry63% | $26 → $25 | Maintains | Outperform | Get Alert |
| 06/25/2015 | LLY | Buy Now | Eli Lilly | $804.99 | — | Jason Gerberry63% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/04/2015 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Jason Gerberry63% | $24 → $25 | Maintains | Outperform | Get Alert |
| 01/09/2015 | ABBV | Buy Now | AbbVie | $190.16 | -63.19% | Jason Gerberry63% | → $70 | Downgrade | Buy → Neutral | Get Alert |
| 01/09/2015 | LLY | Buy Now | Eli Lilly | $804.99 | — | Jason Gerberry63% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/24/2014 | MRK | Buy Now | Merck & Co | $80.60 | -23.08% | Jason Gerberry63% | $57 → $62 | Maintains | Buy | Get Alert |
| 04/24/2014 | ABBV | Buy Now | AbbVie | $190.16 | -71.08% | Jason Gerberry63% | $58 → $55 | Maintains | Buy | Get Alert |
| 04/01/2014 | LLY | Buy Now | Eli Lilly | $804.99 | -91.43% | Jason Gerberry63% | $67 → $69 | Maintains | Buy | Get Alert |
| 02/21/2014 | ABBV | Buy Now | AbbVie | $190.16 | -69.5% | Jason Gerberry63% | $56 → $58 | Maintains | Buy | Get Alert |
| 12/31/2013 | ABBV | Buy Now | AbbVie | $190.16 | -70.55% | Jason Gerberry63% | $53 → $56 | Maintains | Buy | Get Alert |
| 05/01/2013 | AGN | Buy Now | Allergan | — | — | Jason Gerberry63% | $120 → $110 | Maintains | Buy | Get Alert |
| 04/26/2013 | ALKS | Buy Now | Alkermes | $30.12 | -3.72% | Jason Gerberry63% | $24 → $29 | Downgrade | Neutral → Underperform | Get Alert |
| 03/11/2013 | ABBV | Buy Now | AbbVie | $190.16 | -77.91% | Jason Gerberry63% | $40 → $42 | Maintains | Buy | Get Alert |
| 03/04/2013 | MYL | Buy Now | Mylan | — | — | Jason Gerberry63% | $33 → $34 | Maintains | Buy | Get Alert |
| 03/04/2013 | MRK | Buy Now | Merck & Co | $80.60 | -41.69% | Jason Gerberry63% | → $47 | Upgrade | Neutral → Buy | Get Alert |
| 02/25/2013 | JAZZ | Buy Now | Jazz Pharmaceuticals | $109.51 | -32.43% | Jason Gerberry63% | → $74 | Initiates | → Buy | Get Alert |
| 02/01/2013 | ALKS | Buy Now | Alkermes | $30.12 | -20.32% | Jason Gerberry63% | $23 → $24 | Downgrade | Buy → Neutral | Get Alert |
| 01/23/2013 | AGN | Buy Now | Allergan | — | — | Jason Gerberry63% | $106 → $110 | Maintains | Buy | Get Alert |
| 01/09/2013 | LLY | Buy Now | Eli Lilly | $804.99 | -92.55% | Jason Gerberry63% | $57 → $60 | Maintains | Buy | Get Alert |
| 11/26/2012 | MYL | Buy Now | Mylan | — | — | Jason Gerberry63% | — | Initiates | → Overweight | Get Alert |
| 10/11/2012 | LLY | Buy Now | Eli Lilly | $804.99 | -92.92% | Jason Gerberry63% | $52 → $57 | Maintains | Buy | Get Alert |
| 08/29/2012 | LLY | Buy Now | Eli Lilly | $804.99 | -93.54% | Jason Gerberry63% | $46 → $52 | Maintains | Buy | Get Alert |
| 08/24/2012 | MRK | Buy Now | Merck & Co | $80.60 | -44.17% | Jason Gerberry63% | → $45 | Downgrade | Buy → Neutral | Get Alert |
| 06/28/2012 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Jason Gerberry63% | $5 → $7 | Maintains | Underperform | Get Alert |
| 06/07/2012 | MYL | Buy Now | Mylan | — | — | Jason Gerberry63% | $26 → $27 | Maintains | Buy | Get Alert |
| 05/07/2012 | LLY | Buy Now | Eli Lilly & | $804.99 | -94.29% | Jason Gerberry63% | $43 → $46 | Maintains | Buy | Get Alert |
| 04/10/2012 | AGN | Buy Now | Allergan | — | — | Jason Gerberry63% | $100 → $106 | Maintains | Buy | Get Alert |
